Skip to content

Author

M. Mohiuddin

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Targeting the PI3K/Akt Signaling Pathway: A Promising Therapeutic Strategy to Reduce Cancer Mortality and Overcome Chemoresistance

ABSTRACT Background and Aims The phosphatidylinositol 3‐kinase (PI3K)/Akt signaling pathway is a central regulator of cellular properties that are essential for cancer progression, including cellular growth, survival, metabolism, and angiogenesis. Dysregulated PI3K/Akt signaling, often caused by genetic alterations in...

M. Mohiuddin · 0 citations
#gene editing Review Open access Sep 2026

CRISPR‐Cas9 in Cancer Therapy: Overcoming Delivery Barriers and Off‐Target Effects for Clinical Translation

It is argued that improvements in editing efficiency alone will be insufficient; clinical success will require the simultaneous achievement of tumor‐selective delivery, genomic integrity, and acceptable long‐term safety, and the continued development of novel approaches should be promoted to realize the full potential...

M. Mohiuddin, Md Al Mamun Ahsan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.